| Literature DB >> 36119574 |
Xiao-Xiao Zhang1,2, Jia-Qi Zuo1, Yi-Ting Wang1, Hui-Yun Duan1, Jun-Hui Yuan2, Yong-Hong Hu2.
Abstract
Paeoniflorin, a monoterpene glucoside, is increasingly used in the clinical treatment of many diseases because it has a variety of pharmacological activities. Besides, paeoniflorin has been considered the characteristic chemical constituent of Paeoniaceae plants since it was first reported in 1963. Therefore, how to better develop and utilize paeoniflorin in Paeoniaceae has always been a research hotspot. We reviewed the current knowledge on paeoniflorin in Paeoniaceae, with particular emphasis on its distribution and influencing factors. Moreover, the limited understanding of the biosynthesis pathway has restricted the production of paeoniflorin by synthetic biology. This review provides insights into the post-modification pathway of paeoniflorin biosynthesis and proposes directions for further analysis in the future.Entities:
Keywords: Monoterpene; Paeoniaceae; Paeoniflorin; biosynthesis; influencing factors; post-modification enzyme
Year: 2022 PMID: 36119574 PMCID: PMC9478390 DOI: 10.3389/fpls.2022.980854
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
Paeoniflorin content in the roots of different species belonging to Paeoniaceae.
|
|
|
|
|
|---|---|---|---|
|
| TLC | 9.0–25.0 |
|
|
| HPLC | 14.1–25.6 |
|
|
| HPLC | 17.4 |
|
|
| HPLC-MS | 5.8–7.6 |
|
|
| HPLC-MS | 14.0–24.2 |
|
|
| HPLC | 13.7–46.8 |
|
|
| HPLC-MS | 6.0–8.7 |
|
|
| HPLC-MS | 17.2–19.6 |
|
|
| HPLC | 43.4–48.2 |
|
|
| HPLC-MS | 12.3–14.0 |
|
|
| HPLC-MS | 9.8 |
|
|
| TLC | 7.9–18.8 |
|
|
| TLC | 7.8–19.3 |
|
|
| HPLC-MS | 1.9–16.2 |
|
| TLC | 14.2–25.2 |
| |
| RT-HPLC | 7.6–18.2 |
| |
|
| HPLC-MS | 0.9–2.3 |
|
|
| TLC | 28.1–107.2 |
|
|
| RT-HPLC | 23.3–75.5 |
|
|
| HPLC-MS | 22.2–92.3 |
|
| TLC | 49.6–57.0 |
| |
| RT-HPLC | 64.5–77.8 |
| |
|
| TLC | 13.4–57.6 |
|
|
| RT-HPLC | 41.3–52.1 |
|
|
| HPLC-MS | 12.1–90.6 |
|
| TLC | 34.7 |
| |
| TLC | 9.6 |
| |
| RT-HPLC | 33.8 |
| |
|
| TLC | 2.7–24.6 |
|
|
| RT-HPLC | 14.7 |
|
|
| HPLC-MS | 0.5–33.5 |
|
| TLC | 0.9–25.4 |
| |
| RT-HPLC | 38.2 |
| |
| HPLC-MS | 6.9–21.6 |
| |
|
| TLC | 5.6 |
|
|
| HPLC-MS | 24.5–51.7 |
|
|
| HPLC-MS | 24.7–53.3 |
|
|
| HPLC-MS | 3.1–18.9 |
|
|
| TLC | 26.6–27.2 |
|
|
| RT-HPLC | 14.0–30.7 |
|
|
| HPLC-MS | 14.5–29.5 |
|
|
| TLC | 13.0 |
|
|
| RT-HPLC | 26.2 |
|
|
| HPLC-MS | 6.9–64.7 |
|
| TLC | 13.9–24.0 |
| |
| RT-HPLC | 22.1 |
| |
|
| TLC | 13.3–14.8 |
|
|
| RT-HPLC | 29.5 |
|
|
| RT-HPLC | 11.1 |
|
|
| TLC | 16.1–25.7 |
|
|
| TLC | 17.8–21.6 |
|
|
| TLC | 23.1–42.5 |
|
|
| TLC | 16.2 |
|
|
| TLC | 6.8 |
|
| TLC | 14.4 |
| |
|
| TLC | 14 |
|
|
| TLC | 8.3 |
|
| TLC | 4 |
|
The content in the original study was expressed as the percentage.
Figure 1Biosynthesis pathway of paeoniflorin. G3P, glyceraldehyde-3-phosphate; MVA, mevalonate; MEP, 2-C-methyl-D-erythritol4-phosphate; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl diphosphate; IDI, isopentenyl diphosphate isomerase; GPS, geranylgeranyl pyrophosphate synthase; GPP, geranyl diphosphate; PS, pinene synthase.
Figure 2Predicted synthesis of paeoniflorin catalyzed by glycosyltransferase and benzoyltransferase. The substrate of glycosyltransferase is paeoniflorgenin and the glycosyl donor is uridine diphosphate glucose. The substrate of benzoyltransferase is 8-debenzoylpaeoniflorin and the benzoyl donor is benzoyl-CoA.
Figure 3Predicted biosynthesis pathway of the hemiketal–acetal linkage of paeoniflorin. Compounds 1 and 3 are possible intermediates; the representative of compound 2 is mudanpioside F; the representatives of compound 4 are paeonisuffrone and 1-O-D-glucopyranosyl-8-O-benzoylpaeonisuffrone; the representative of compound 5 is paeonidaninol A; the representative of compound 6 is paeoniflorin; R1 and R2 represent the possible modification groups.